Amsterdam Molecular Therapeutics prices IPO at 10 eur, top of range |
|
|
|
Published
:
Wed, 20 Jun 2007 07:47 |
AMSTERDAM (Thomson Financial) - Human gene therapy specialist Amsterdam Molecular Therapeutics set a final price of 10 eur per share for its initial public offering, at the top of the indicative range of 8-10 eur.The IPO consisted of 5 mln new shares.Based on the final IPO price, AMT will have a market capitalisation of 139 mln eur when trade begins on Euronext Amsterdam at 11 am today, it said.Andrew.Newby@Thomson.comanCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
|
|
|
|